New preclinical findings from extensive cell and animal studies suggest that a drug already used for a rare kidney disease could benefit patients with some mitochondrial disorders -- complex conditions with severe energy deficiency for which no proven effective treatments exist. Future clinical research is needed to explore whether the drug, cysteamine bitartrate, will meaningfully benefit patients.
from Latest Science News -- ScienceDaily https://ift.tt/2Ua8jKo
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment